NCT06277505

Brief Summary

In this study, we will evaluate the efficacy of prebiotics combined with quadruple probiotics in the treatment of functional constipation through an open RCT study. The experimental group received lifestyle guidance and combined intervention of prebiotics and quadruple probiotics at the same time. The patients took the combination of prebiotics and probiotics twice a day during the treatment period. The control group received only lifestyle instruction. At the same time, to evaluate the safety of probiotics combined with quadruple probiotics in the treatment of functional constipation, and provide a new treatment plan for clinical treatment of functional constipation.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

May 1, 2024

Status Verified

March 1, 2024

Enrollment Period

1.1 years

First QC Date

February 18, 2024

Last Update Submit

April 29, 2024

Conditions

Keywords

prebioticsprobioticsfunctional constipationRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change in the number of fully autonomous bowel movements per week at the end of treatment

    Change in the number of fully autonomous bowel movements per week at the end of treatment

    A month after treatment

Study Arms (2)

Prebiotics and probiotics,life-style

EXPERIMENTAL

Take 3.5g prebiotic +2g probiotic twice a day before meals; At the same time, lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise

Combination Product: Take prebiotics and probioticsBehavioral: lifestyle guidance

life-style

OTHER

lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise

Behavioral: lifestyle guidance

Interventions

Take 3.5g prebiotic +2g prebiotic twice a day before meals; At the same time, lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise

Also known as: behavioral
Prebiotics and probiotics,life-style

lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise

Prebiotics and probiotics,life-stylelife-style

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age: between 18 and 60 years old
  • Functional constipation was diagnosed using Rome IV criteria.
  • No other relevant medications that may affect the gut microbiota before the start of the experiment
  • Ability to participate
  • Consent to participate in the study

You may not qualify if:

  • Organic constipation (such as intestinal obstruction, bowel cancer, etc.)
  • Outlet obstructive constipation
  • Previous abdominal, rectal, or perianal surgery except cholecystectomy, appendectomy, tubal ligation, and cesarean section
  • Patients with constipation-oriented irritable bowel syndrome (IBS-C) or functional abdominal pain syndrome who meet Rome IV criteria
  • a serious mental illness or any medical condition related to it
  • Diseases of the small or large intestine, such as ulcerative colitis and Crohn's disease
  • There are serious important organs such as respiratory, heart, liver, kidney and other functional insufficiency
  • Use probiotics, prebiotics and/or Biostime within 1 month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Xiamen Univisity

Xiamen, Fujian, 350000, China

Location

MeSH Terms

Interventions

Probiotics

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2024

First Posted

February 26, 2024

Study Start

May 1, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

May 1, 2024

Record last verified: 2024-03

Locations